ABMD 33.00 Abiomed $ABMD Hit a 52 week high of 33.18

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 10:05 AM

ABMD 33.00 Abiomed $ABMD Hit a 52 week high of 33.18 Currently at 33.00 +0.01 +0.03% With a day low of 32.90 and a total volume of 85,086.

ABMD Abiomed Recent Headline News

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 54 mins ago
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 32.98 (-0.01), ROKA: 3.64 (+0.06), EW: 124.64 (+0.04), ANGO: 16.93 (-0.03)

OTC Daily Alert Stock Watch - ABIOMED, Inc. (NASDAQ: ABMD)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
ABMD: 32.98 (-0.01)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 32.98 (-0.01), VOLC: 10.60 (+0.06), EW: 124.64 (+0.04), ANGO: 16.93 (-0.03)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 32.98 (-0.01), DXCM: 52.92 (-0.58), EW: 124.64 (+0.04), ANGO: 16.93 (-0.03)

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 107.62 (-1.33), ABMD: 32.98 (-0.01), JNJ: 108.88 (+0.06), AMGN: 162.50 (-0.59), EXAS: 22.43 (-0.17), ARAY: 6.88 (-0.02), HOLX: 26.59 (+0.04), PBYI: 239.95 (-4.84)

Update: Abiomed's Q2 Fiscal 2015 Earnings Remained Impressive
Andy Batts - at Seeking Alpha - Sat Nov 08, 4:40PM CST

ABMD: 32.98 (-0.01)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 32.98 (-0.01), DXCM: 52.92 (-0.58), ANGO: 16.93 (-0.03), HOLX: 26.59 (+0.04)

Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:00AM CST
Following the earnings release, shares of Thoratec Corp. (THOR) declined approximately 3.5% to close at $26.10 yesterday.
ABMD: 32.98 (-0.01), CYNO: 25.37 (-0.04), THOR: 27.56 (+0.26), ANGO: 16.93 (-0.03)

Abiomed (ABMD) Upgraded From Hold to Buy
at The Street - Fri Nov 07, 8:07AM CST
Abiomed (ABMD) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
ABMD: 32.98 (-0.01)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 32.98 (-0.01), DXCM: 52.87 (-0.63), FMI: 24.21 (-0.50), ANGO: 16.93 (-0.03)

Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 32.98 (-0.01), FLDM: 28.58 (-0.42), ANGO: 16.93 (-0.03), MR: 30.99 (+0.39)

Abiomed Tops Q2 Earnings, Revenues; FY15 Sales View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:10PM CST
Abiomed Inc. (ABMD) reported second-quarter fiscal 2015 earnings of 9 cents per share, outshining the Zacks Consensus Estimate of 2 cents.
ABMD: 32.98 (-0.01), FLDM: 28.58 (-0.42), BEAT: 8.29 (+0.09), ANGO: 16.93 (-0.03)

Downgrade Alert for ABIOMED (ABMD)
Comtex SmarTrend(R) - Mon Nov 03, 7:58AM CST
ABIOMED (NASDAQ:ABMD) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $32.79 on volume of 1.3 million shares, above average daily volume of 260,000. ABIOMED share prices have moved between a 52-week high of $32.99 and a 52-week low of $20.29 and closed yesterday at 62% above that low price at $32.79 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.1% while the 200-day MA has remained constant.
ABMD: 32.98 (-0.01)

Abiomed ups earnings 246% in FQ2
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 8:18AM CDT

ABMD: 32.98 (-0.01)

Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 29.57 (-0.58), ABMD: 32.98 (-0.01), BGFV: 12.92 (-0.01), RDCM: 9.13 (+0.02), AMED: 25.30 (+0.16), MRCY: 13.71 (-0.04), OMER: 18.95 (+1.46), ESBF: 18.72 (-0.11), EVOK: 6.76 (+0.06), IQNT: 17.46 (+0.04), KONA: 22.90 (-0.22), TQNT: 22.25 (-0.05), LAKE: 12.90 (-0.08), SAJA: 5.60 (-0.19)

Ocwen Financial Climbs Despite Earnings Shortfall
at The Street - Thu Oct 30, 4:20PM CDT
ABIOMED, Inc. (NASDAQ:ABMD), Calix Inc (NYSE:CALX) and Ocwen Financial Corp (NYSE:OCN) are today's top-gaining billionaire stock picks. In the red this Thursday are Yamana Gold Inc. (NYSE:AUY), Wes...
ABMD: 32.98 (-0.01), CALX: 11.51 (+0.13), OCN: 22.34 (+0.38), AUY: 3.87 (+0.21), WSTL: 1.39 (+0.01)

ABIOMED's (ABMD) CEO Mike Minogue on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:07PM CDT

ABMD: 32.98 (-0.01)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:47AM CDT

ABMD: 32.98 (-0.01), CALX: 11.51 (+0.13), LOJN: 2.69 (-0.06), ALU: 3.16 (-0.01), CDTI: 2.57 (-0.07), NKA: 4.75 (-0.08), ARAY: 6.88 (-0.02), GLUU: 3.74 (-0.05), PDII: 1.72 (-0.03), OMER: 18.95 (+1.46), ESBF: 18.72 (-0.11), CRNT: 1.12 (-0.02), CBDE: 0.80 (-0.13), PRXL: 54.55 (+0.05), BWEN: 6.52 (-0.03), ALDX: 7.84 (-0.07), BBSI: 23.55 (-0.73), LAKE: 12.90 (-0.08), OPHC: 0.92 (unch), WTW: 25.67 (+0.05)

Abiomed tops Street 2Q forecasts
Automated Insights - Thu Oct 30, 7:28AM CDT
DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Thursday reported profit of $3.8 million in its fiscal second quarter.
ABMD: 32.98 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Landis+Gyr's Big Contract Victory: A Game Changer?

Diving into Landis+Gyr's Major Utility Win When news hits about a deal secured by Landis+Gyr Group AG, it rings a few bells across the utility landscape. These folks have brewed up a storm with a fresh contract that slots into their rapidly expanding portfolio of grid-savvy products. So, what’s the fuss about this latest agreement? A Groundbreaking Contract Now, this...

Artprice Champions Creative Freedom with AI in 2026

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Cognizant & EBRD Unite for Tech Transformation Push

An Unexpected Collaboration to Watch Sometimes partnerships come out of left field, like this one between Cognizant and the European Bank for Reconstruction and Development (EBRD). These two are teaming up to inject some serious tech smarts into the Bank's operations over the next five years. What's interesting here is the role AI and automation play in their grand...

Key Sewer Line Damage Signs Homeowners Often Ignore

Spotting Trouble Beneath the Surface Now, when was the last time you eyeballed your home’s plumbing with more than a passing glance? Most folks don’t give their sewer lines two thoughts until something foul pops up. Plumbing expert Jessica Gerdeman from Heggemann, Inc. in Warrenton, Missouri, isn’t just blowing hot air when she points out the indicators of looming...

CSQR Faces Scrutiny Over Cash Flow Discrepancies

Dalrymple's Short Report Shakes Csquare's Core Csquare, Inc. (NYSE: CSQR) is reeling from a one-two punch: a damning short report by Dalrymple Finance and an 11.8% share tumble. The timing of this financial body blow, coinciding with Csquare's discordant cash flow claims, could mark the beginning of a long battle for investor trust. This ain't the first time the markets...

Keeper Security Shines in Gartner's 2026 PAM Report

Recognition That Stands Out When you're in the security game, being flagged in the Gartner® Magic Quadrant™ is like getting the thumbs-up from the industry's toughest critic. Keeper Security just snagged that recognition for the second year straight, and what's putting feathers in their cap? A completeness of vision and the chops to execute—no small feat in the wild...

MacDonald Steps Up as President at California Bank

New Leadership at California Bank & Trust It's a big shakeup in the banking lanes today as Michael MacDonald grabs the helm at California Bank & Trust (CB&T). He's stepping into the President's shoes, bringing along a toolkit of experience and know-how that's tough to find elsewhere. Under his watch, CB&T aims to blend the nimble maneuvering of local banks with the clout...

PG&E Halts Service; Groups Demand Regulatory Action

Pending Storm Over PG&E's Service Delays It's rare that you hear a utility company flat-out say it can't afford to keep the lights on. Yet here we are, staring down the barrel of some unsettling news for 25,000 PG&E customers. They've been warned they might cool their heels for an extra six months before their service is up and running. As if that's not dicey enough, $2...

Ademi LLP Questions RRC Buyout Deal's Fairness

Unease Surrounds RRC's Potential Acquisition by EQT Let’s talk about a messy situation brewing with Range Resources Corporation (NYSE: RRC). The lawyers at Ademi LLP are poking around in the shadows of a proposed buyout by EQT Corporation, questioning whether the deal is legit—or if someone’s getting the short end of the stick. It’s all happening in a climate...